EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies

OBJECTIVE: Value frameworks in oncology have not been validated for the assessment of treatments in haematological malignancies, but to avoid overlaps and duplications it appears reasonable to build up experience on existing value frameworks, such as the European Society for Medical Oncology—Magnitu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:ESMO Open
Main Authors: Kiesewetter, Barbara, Cherny, Nathan I, Boissel, Nicolas, Cerisoli, Francesco, Dafni, Urania, de Vries, Elisabeth G E, Ghia, Paolo, Gökbuget, Nicola, González-Calle, Verónica, Huntly, Brian, Jäger, Ulrich, Latino, Nicola Jane, Douillard, Jean-Yves, Malcovati, Luca, Mateos, María-Victoria, Ossenkoppele, Gert J, Porkka, Kimmo, Raderer, Markus, Ribera, Josep-Maria, Scarfò, Lydia, Wester, Ruth, Zygoura, Panagiota, Sonneveld, Pieter
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7003483/
https://ncbi.nlm.nih.gov/pubmed/31958292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000611
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki